Tag: ARVAC Cecilia Grierson

• Thursday, October 19th 2023 - 10:49 UTC

  Argentine-made Covid-19 vaccine approved

  

  Argentine health authorities Tuesday approved a booster Covid-19 vaccine fully developed in the South American country, it was announced Wednesday in Buenos Aires. The “ARVAC Cecilia Grierson” drug is said to be effective against the latest versions of the disease for patients over 18 years of age.

• Tuesday, December 27th 2022 - 08:05 UTC

  More funding for Argentine-developed Covid-19 booster jab

  

  Argentina's National Agency for the Promotion of Research, Technological Development and Innovation (Agencia I+D+i) granted funding worth AR$ 1.1 billion (around US$ 3.18 million at the unofficial exchange rate) to carry out clinical studies of phases II and III of the “ARVAC Cecilia Grierson” Covid 19 vaccine, it was reported.